(Date:11/24/2009)...,, ,Primaryefficacyendpointhasbeenmetforpatien... , QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AE...ny"),aglobalbiopharmaceuticalcompanyfocusedonendoc...acydatafromaPhase2studywithitstargetedcytotoxicpep...ithadvancedorrecurrentendometrialcancer.Inapersona...
(Date:11/24/2009)...,, REDWOODCITY,Calif.,Nov.24/PRNewswire-First...ncedthatRandyScott,GenomicHealth,sExecutiveChairma...ConferenceinNewYorkCityonTuesday,December1,2009at1...chivedwebcastofthepresentation,visittheInvestorRel...estor.genomichealth.com .Pleaseconnecttothewebsite...
(Date:11/24/2009)...,, SEATTLE,Nov.24/PRNewswire-FirstCall/--Cell...twillpresentatthe21stAnnualPiperJaffrayHealthCareC...attheNewYorkPalaceHotel. ,, CTIwillpresentonTue...loor).AliveaudiowebcastofCTI,spresentationwillbeav...eavailableforreplayafterwards. , ,PiperJaffrayHea...
(Date:11/23/2009)... Graphene consists of a two-dimensional carbon la...xagonal lattice, resembling a honeycomb. Carbon na...k piles of graphene sheets form graphite. Graphene...xtremely tear-resistant, an excellent thermal cond...s brittleness and ductility. In addition, graphene...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2Polymer with honeycomb structure 2...nc. (Nasdaq: ACUR ) reported 2007 fourth quarter ...hare compared to net income,of $3.9 million, or $0...,the non-cash deemed dividend discussed below) for...mber 31, 2007, the Company reported a net loss of,... loss of $6.0 million, or,$0.75 per share for 2006...
...SON, N.J., March 5 Quest Diagnostics,Incorporated...lected by,FORTUNE magazine to the 2008 list of Ame...as ranked third among four companies in the "Healt... 2008 marks the first year,the company has been na... admired companies in America is a,tribute to the ...
...undestag (Lower House) is due to vote on an amendm...s in the debate on embryonic stem cell research,co...ng for the complete,liberalisation of stem cell re...al ban on the use of human stem cells, which are p...on a new regulation, Blasticon,Biotechnologische F...
Other Biology Technology:Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations 2Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations 3Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations 4Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations 5Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations 6Quest Diagnostics Named to FORTUNE Magazine's America's Most Admired Companies List 2A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy 2A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy 3...) Thermo Scientific (Part of Thermo Fisher Scienti...n, introduces the latest product innovation for la...liability and performance platform of Thermo's DSQ...es the new DynaMax XR ion detection system and the...
Murashige and Skoog Basal Medium with Gamborg's Vitamins from Sigma-Aldrich
...dization chamber assembly (1 each) Components (ch...rray chamber user guide plastic tweezersChambers ... and reused. The chamber is designed for use with ...tom oligo microarrays, in conjunction with Agilent...
Iscove's Modified Dulbecco's Medium (IMDM) from Sigma-Aldrich
Biology Products: